ONYX PHARMACEUTICALS

DC

A biopharmaceutical company

Active 2010–2015. The register lists this client once for every firm that files on its behalf; all 4 of its records are shown together here.

Filings
59
Filed By
4
Reported In-House
$390,000
Reported By Firms
$715,000

These two figures are not added together. A client that lobbies for itself reports its own spending, while firms it retains report what they were paid. Disclosure rules ask the in-house figure to include those payments, but filings do not always do so, and a filing gives no way to tell. Each is shown as reported.

Filings

YearFirmPeriodAmountDoc
2015 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Termination (No Activity)
$30,000
2015 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 3rd Quarter (July 1 - Sep 30)
AMENDED
$30,000
2015 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report (No Activity)
$30,000
2015 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Report
$30,000
2015 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 1st Quarter (Jan 1 - Mar 31)
1st Quarter - Report
$30,000
2014 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report
$30,000
2014 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
$30,000
2014 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Report
$30,000
2014 FOLEY HOAG LLP 1st Quarter (Jan 1 - Mar 31)
1st Quarter - Termination (No Activity)
—
2014 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 1st Quarter (Jan 1 - Mar 31)
1st Quarter - Report
$30,000
Page 1 of 6  ·  59 filings Next
Filed By
Issue Areas

Bills Mentioned in Filings